Home
About this system
Release history
Contact us

ANTIKOR BIOPHARMA LIMITED

NN14 4LN (East Midlands)

Go back

Reset results to starting set

The following are buttons which change the sort order, pressing the active button will toggle the sort order

Start Date

descending (press to sort ascending)

End Date Funded Value Relevance

CSV

Download all search results to a CSV file?

Large result sets may take several minutes to download.
The first row is header row.
Generation of CSV export files is restricted, and may be rejected during busy periods. If this happens then please wait and try again after a brief interval.

25 50 100

Refine

£499,155

Mar 23 - Sep 24

Harnessing FDC technology for metastatic colorectal cancer (mCRC)

Innovate UK award to ANTIKOR BIOPHARMA LIMITED and Mahendra Deonarain

£1,242,164

Mar 22 - Mar 24

Advanced preclinical development of a solid tumour-tailored gastric cancer therapy

Innovate UK award to ANTIKOR BIOPHARMA LIMITED and Mahendra Deonarain

£74,963

May 20 - Feb 21

Accelerated Coronavirus clearance immunotherapy

Innovate UK award to ANTIKOR BIOPHARMA LIMITED and Mahendra Deonarain

£120,300

May 20 - Feb 21

Gastric Cancer Antibody Fragment Drug Conjugate: Promising candidate to manufacturable product (Continuation)

Innovate UK award to ANTIKOR BIOPHARMA LIMITED and Mahendra Deonarain

£349,466

Dec 19 - May 21

Gastric Cancer Antibody Fragment Drug Conjugate: Promising candidate to manufacturable product

Innovate UK award to ANTIKOR BIOPHARMA LIMITED and Mahendra Deonarain

£365,629

Feb 19 - Jul 20

Improved Linkers for Antibody Fragment Drug Conjugates

Innovate UK award to ANTIKOR BIOPHARMA LIMITED and Mahendra Deonarain

£809,960

Jan 17 - Dec 18

Antibody Fragment Drug Conjugates - Overcoming the challenge in treating Gastric Cancer

Innovate UK award to ANTIKOR BIOPHARMA LIMITED

£100,000

Dec 14 - May 16

Novel, multi-action payloads for antibody drug conjugates

Innovate UK award to ANTIKOR BIOPHARMA LIMITED

£143,102

Nov 13 - Oct 14

A theranostic approach for gastric cancer

Innovate UK award to ANTIKOR BIOPHARMA LIMITED

£645,701

May 13 - Sep 15

Antibody Directed Phototherapy for Oesophageal Adenocarcinoma

Innovate UK award to ANTIKOR BIOPHARMA LIMITED

£94,200

Nov 12 - Jan 14

OptiLinked Antibody Drug Conjugates for Cancer Therapy

Innovate UK award to ANTIKOR BIOPHARMA LIMITED

Help

Refine by :

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}

Data

The Data on this website provides information about publications, people, organisations and outcomes relating to research projects

APIs

A set of REST API's enable programmatic access to the data. Refer to the application programming interfaces GtR and GtR-2

Contact

UKRI Gateway
Polaris House
Swindon
SN2 1ET
gateway@ukri.org

Privacy | Terms of Use | OGL Data last updated: 18 Apr 2024